Skip to content

Manuel Pedro Marques da Silva

    • 5h-indexImpact measure calculated using publication and citation counts. Updated daily.
    • 116CitationsNumber of citations received by Manuel Pedro's publications. Updated daily.

    Other IDs

    Co-authors (85)

    Publications (5)

    • Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension

      • Marques da Silva P
      • Haag U
      • Guest J
      • et al.
      N/AReaders
      7Citations
      Get full text
    • Prevalence of microalbuminuria in hypertensive patients with or without type 2 diabetes in a Portuguese primary care setting: The RACE (micRoAlbumin sCreening survEy) study | Prevalência da microalbuminúria em doentes hipertensos e/ou diabéticos tipo 2 no

      • Marques Da Silva P
      • Carvalho D
      • Nazaré J
      • et al.
      N/AReaders
      4Citations
      Get full text
    • The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice

      • Sattar N
      • Ginsberg H
      • Ray K
      • et al.
      N/AReaders
      48Citations
      Get full text
    • Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorv

      • Hobbs F
      • Gensini G
      • Mancini G
      • et al.
      N/AReaders
      18Citations
      Get full text
    • Atorvastatin versus bezafibrate in mixed hyperlipidaemia: Randomised clinical trial of efficacy and safety (the ATOMIX study)

      • Ros E
      • Oliván J
      • Mostaza J
      • et al.
      N/AReaders
      0Citations
      Get full text